Table 6 Pathological results
Neoadjuvant ( n = 80) | Adjuvant ( n = 90) | P | |
|---|---|---|---|
Clinical/pathological tumor stage | 0.323/<0.001 | ||
T0 | 0 (0%)/12 (15.0%) | 0 (0%)/0 (0%) | |
T1 | 4 (5.0%)/9 (11.2%) | 1 (1.1%)/1 (1.1%) | |
T2 | 7 (8.8%)/24 (30.0%) | 10 (11.1%)/8 (8.9%) | |
T3 | 16 (20.0%)/15 (18.8%) | 13 (14.4%)/16 (17.8%) | |
T4 | 53 (66.3%)/20 (25.0%) | 66 (73.4%)/65 (72.2%) | |
Nodal status | <0.001 | ||
N0 | 47 (58.8%) | 13 (14.4%) | |
N1 (one to two nodes involved) | 13 (16.3%) | 20 (22.2%) | |
N2 (three to six nodes involved) | 11 (13.8%) | 25 (27.8%) | |
N3 (more than seven nodes involved) | 9 (11.3%) | 32 (35.6%) | |